Investment Research & Advisory Group’s Pfenex Inc. PFNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-65,826
Closed -$3.45M 182
2022
Q2
$3.45M Buy
65,826
+2,400
+4% +$126K 2.5% 9
2022
Q1
$3.28M Buy
63,426
+1,060
+2% +$54.9K 2.06% 11
2021
Q4
$3.68M Sell
62,366
-2,000
-3% -$118K 2.24% 12
2021
Q3
$2.78M Buy
64,366
+445
+0.7% +$19.2K 1.83% 15
2021
Q2
$2.5M Buy
63,921
+573
+0.9% +$22.4K 1.65% 16
2021
Q1
$2.29M Buy
63,348
+5,044
+9% +$183K 1.69% 20
2020
Q4
$2.15M Buy
58,304
+8,652
+17% +$318K 1.59% 21
2020
Q3
$1.82M Buy
49,652
+1,443
+3% +$15.3K 1.51% 18
2020
Q2
$1.56M Buy
48,209
+26,206
+119% +$196K 1.4% 22
2020
Q1
$718K Buy
22,003
+11,775
+115% +$129K 0.67% 26
2019
Q4
$401K Buy
+10,228
New +$102K 0.37% 34

Investment Research & Advisory Group's PFNX Position: Q3 2022 in Review

Investment Research & Advisory Group sold out of Pfenex Inc. (PFNX) in Q3 2022, closing a stake of 65,826 shares — an estimated $3.45M sold.

Investment Research & Advisory Group first reported a position in PFNX in Q4 2019 and held it in 11 quarters. The position peaked at $3.68M in Q4 2021. 0 funds tracked by Wall St. Rank hold PFNX as of Q3 2022.

  • Investment Research & Advisory Group reported no remaining Pfenex Inc. position as of Q3 2022 after selling out during the quarter.
  • Investment Research & Advisory Group sold 65,826 Pfenex Inc. shares in Q3 2022, an estimated $3.45M.
  • Investment Research & Advisory Group first reported a position in Pfenex Inc. in Q4 2019 and held it in 11 quarters.
  • Investment Research & Advisory Group's Pfenex Inc. position peaked at $3.68M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Pfenex Inc. as of Q3 2022.

Based on Investment Research & Advisory Group's 13F filing for Q3 2022, filed 18 Oct 2022.